ArticleFood chemistry: X2026
Preparation of sea cucumber collagen hydrolysate and its inhibitory effect on α-glucosidases.
Article in Food chemistry: X, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Emerging role of ultrasound in food technology: principles, applications, and future prospects.Journal of ultrasound · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Non-alcoholic fatty liver disease (NAFLD) is a chronic metabolic disorder characterized by excessive hepatic lipid accumulation. Emerging evidence suggests that digestive enzymes such as α-glucosidase regulate lipid and glucose homeostasis through postprandial metabolic pathways and may represent a potential therapeutic target for NAFLD management. This study investigated the α-glucosidase inhibitory activity of sea cucumber collagen peptides. Five collagen hydrolysates were prepared, among which the hydrolysate obtained by pepsin digestion for 2 h followed by trypsin digestion for 3 h (SDP 2 h + T 3 h) exhibited the strongest inhibitory activity. A peptide, RDDPEPSYK (RDD), was isolated and identified as a specific α-glucosidase inhibitor. RDD showed inhibitory efficacy comparable to acarbose and significantly reduced lipid accumulation by downregulating lipid synthesis-related proteins, including SREBP-1C and FAS. These findings suggest that sea cucumber collagen peptides may have potential applications in anti-obesity and anti-hepatic steatosis interventions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.